3.0.0 4439 2023-01-11T13:45:20Z 2023-01-11T13:45:20Z Senate S 2020-08-05 116 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2020-08-05T17:12:35Z MMAPPP Act of 2020 116 7296 HR 2020-06-22 Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS 2020-08-05 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2020-08-05 Introduced in Senate IntroReferral 10000 9 Library of Congress S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN N M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2020-08-05 True B001230 Sen. Baldwin, Tammy [D-WI] Tammy Baldwin D WI 2020-08-05 True G000555 Sen. Gillibrand, Kirsten E. [D-NY] Kirsten Gillibrand D NY E. 2020-08-05 True H001075 Sen. Harris, Kamala D. [D-CA] Kamala Harris D CA D. 2020-08-05 True B001288 Sen. Booker, Cory A. [D-NJ] Cory Booker D NJ 2020-08-06 False M001169 Sen. Murphy, Christopher [D-CT] Christopher Murphy D CT S. 2020-12-11 False Health Business records Cardiovascular and respiratory health Civil actions and liability Corporate finance and management Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Government information and archives Health programs administration and funding Health promotion and preventive care Immunology and vaccination Infectious and parasitic diseases Inflation and prices Intellectual property Licensing and registrations Manufacturing Medical research Medical tests and diagnostic methods Performance measurement Prescription drugs Research administration and funding Research and development User charges and fees Wages and earnings Health 00 2020-08-05 Introduced in Senate 2021-01-28T16:27:08Z Make Medications Affordable by Preventing Pandemic Price gouging Act of 2020 or the MMAPPP Act of 2020

This bill imposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies.

With respect to a COVID-19 drug patent developed using certain types of federal support, any license granted by the federal government shall be open and nonexclusive. Similarly, a licensee or assignee for such a patent shall grant open nonexclusive licenses for the patent. An entity that receives a license shall pay reasonable royalties to (1) the patent holder, or (2) the owner of marketing exclusivity rights granted by the Food and Drug Administration (FDA) that were terminated under this bill.

The bill requires that such drugs be offered at a fair and reasonable price based on certain considerations, such as access.

If the Department of Health and Human Services (HHS) finds that the price of any drug to address a public health emergency is excessive, HHS must void any FDA-granted exclusivity for the drug and grant open and nonexclusive licenses to other manufacturers. Such licenses are subject to reasonable royalty requirements.

]]> MMAPPP Act of 2020 Display Title MMAPPP Act of 2020 Short Title(s) as Introduced MMAPPP Act of 2020 Introduced in Senate IS Short Title(s) as Introduced Make Medications Affordable by Preventing Pandemic Price-gouging Act of 2020 Introduced in Senate IS Official Title as Introduced A bill to require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes. Introduced in Senate IS Introduced in Senate 2020-08-05T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s4439is/xml/BILLS-116s4439is.xml 2020-08-05 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.